# Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses

> **NCT04646980** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 80 (actual)

## Conditions studied

- Influenza-like Illness

## Interventions

- **DIETARY_SUPPLEMENT:** Biobran/MGN-3
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04646980
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-28
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-11-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04646980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04646980, "Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04646980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*